UNIPHAR PLCUNIPHAR PLCUNIPHAR PLC

UNIPHAR PLC

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
0.08EUR
Revenue estimate
‪1.29 B‬EUR
Market capitalization
‪685.27 M‬EUR
‪44.82 M‬EUR
‪2.55 B‬EUR
‪236.39 M‬
Beta (1Y)
1.01

About UNIPHAR PLC

CEO
Gerard Rabbette
Website
Headquarters
Dublin
Founded
1994
ISIN
IE00BJ5FQX74
FIGI
BBG00XH52FN6
Uniphar Plc engages in the provision of services within the pharmaceutical and healthcare sector. It operates through the following segments: Commercial and Clinical; Product Access; and Supply Chain and Retail. The Commercial and Clinical segment provides outsourced services specifically sales, marketing, and multichannel account management to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access segment offers demand and exclusive access services. The Supply Chain and Retail segment focuses on pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons. The company was founded in 1967 and is headquartered in Dublin, Ireland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange UNIPHAR PLC stocks are traded under the ticker UPRI.
UNIPHAR PLC is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
UPRI earnings for the last quarter are 0.07 EUR per share, whereas the estimation was 0.08 EUR resulting in a −6.21% surprise. The estimated earnings for the next quarter are 0.11 EUR per share. See more details about UNIPHAR PLC earnings.
UNIPHAR PLC revenue for the last quarter amounts to ‪1.24 B‬ EUR despite the estimated figure of ‪1.18 B‬ EUR. In the next quarter revenue is expected to reach ‪1.31 B‬ EUR.
Yes, you can track UNIPHAR PLC financials in yearly and quarterly reports right on TradingView.
UPRI net income for the last quarter is ‪29.80 M‬ EUR, while the quarter before that showed ‪15.01 M‬ EUR of net income which accounts for 98.53% change. Track more UNIPHAR PLC financial stats to get the full picture.
UNIPHAR PLC dividend yield was 0.68% in 2023, and payout ratio reached 11.14%. The year before the numbers were 0.56% and 10.40% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, UPRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIPHAR PLC stock right from TradingView charts — choose your broker and connect to your account.
UPRI reached its all-time high on Oct 29, 2021 with the price of 4.400 EUR, and its all-time low was 2.195 EUR and was reached on Oct 3, 2023.
See other stocks reaching their highest and lowest prices.
We've gathered analysts' opinions on UNIPHAR PLC future price: according to them, UPRI price has a max estimate of 5.00 EUR and a min estimate of 3.40 EUR. Read a more detailed UNIPHAR PLC forecast: see what analysts think of UNIPHAR PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNIPHAR PLC EBITDA is ‪112.77 M‬ EUR, and current EBITDA margin is 4.42%. See more stats in UNIPHAR PLC financial statements.